期刊文献+

肝素涂层体外循环管道中聚乙烯亚胺的作用研究 被引量:3

Effects of concentration and molecular weight of polyethyleneimine on heparin-coated modified polyvinyl chloride material
下载PDF
导出
摘要 目的:探讨聚乙烯亚胺(PEI)的浓度、平均相对分子量对涂层肝素的影响,筛选出合适的各种底物的浓度及反应条件,优化涂层工艺。方法:将PEI的平均相对分子量(3 000、10 000、20 000)和质量浓度(1 g/dl、2 g/dl、5 g/dl)交叉组合分为9个组,制成PEI-戊二醛-肝素涂层体外循环管道。利用红外光谱对结合肝素的表征定性,用甲苯胺蓝分光光度法测量肝素的结合含量。结果:通过PEI-戊二醛-肝素涂层体外循环管道肝素的结合量,受PEI的分子量及浓度的影响,最适质量浓度及平均相对分子量分别为2 g/dl和20 000。结论:各组肝素涂层材料肝素的浓度随PEI平均相对分子量的递增而增加,在一定范围内,PEI的浓度与肝素的含量呈正相关,浓度过高或过低均不利于肝素的结合。 AIM: To study the effects of concentration and molecular weight of polyethyleneimine (PEI) on PEI-heparin-coated polyvinyl chloride (PVC) medical materials. METHODS: Using PEI-glutaralde- hyde-heparin coating techniques, cardiopulmonary bypass (CPB) circuits were coated with heparin and then divided into nine groups by PEI concentrations and molecular weights. The content of the coated heparin was calculated by toluidine blue spectrophotometry. RESULTS: The combination of the amount of heparin on PEI-heparin-coated PVC medical material was affected by the concentration and molecular weight of PEI. The optimal concentration and molecular weight of PEI were 2 g/dl and 20 000, respectively. CONCLUSION: Heparin concentration on PEI-glutaraldehyde-heparin-coated PVC surface is increased by the concentration and molecular weight of PEI. The increase is to some degree positively related to the content of PEI. Too high or too low PEI concentrations are not conducive to the combination of heparin.
出处 《心脏杂志》 CAS 2010年第5期670-672,676,共4页 Chinese Heart Journal
基金 国家自然科学基金项目资助(30700174) 陕西省社发攻关基金课题(2006K12-G5(4)]项目资助
关键词 聚乙烯亚胺 体外循环管道 肝素涂层 polyethyleneimine polyvinyl chloride-heparin coating
  • 相关文献

参考文献12

  • 1Sperling C, Houska M, Brynda E, et al. In vitro hemocompalibility of albumin-heparin muhilayer coatings on polyethersulfone prepared by the layer-by-layer technique[ J ]. J Biomed Mater Res A, 2006, 76(4) : 681 -689.
  • 2Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation [J]. Eur J Cardiothorac Surg, 1999, 16(3) : 342 -350.
  • 3杨剑,易定华,刘金成,胡巧侠,刘剑,曹瑞军,秦锋.肝素涂层体外循环管道的制备及生物学性能评价[J].中国生物医学工程学报,2004,23(2):169-174. 被引量:11
  • 4Hsu LC. Biocompatibility in cardiopulmonary bypass[ J]. J Cardiothoracic Vasc Anesth, 1997, 11 (3) :376 -382.
  • 5张安兄,吕德龙,钟伟,程为庄,杜强国.生物材料的血液相容性[J].上海生物医学工程,2004,25(3):53-58. 被引量:27
  • 6杨剑,易定华.体外循环中的肝素涂层技术[J].国外医学(生物医学工程分册),2003,26(2):89-93. 被引量:3
  • 7Huang LY, Yang MC. Hemocompatibility of layer-by-layer hyalu ronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery [ J ]. J Nanosci Nanotechnol, 2006, 6(9 - 10) :3163 -3170.
  • 8Thorslund S, Sanchez J, Larsson R, et al. Functionality and stability of heparin immobilized onto poly (dimethylsiloxane) [ J ]. Colloids Surf B Biointeofaces, 2005, 45 (2) :76 - 81.
  • 9Lappegard KT, Riesenfeld J, Brekke OL, et al. Differential effect of heparin coating and complement inhibition on artificial surface- induced eicosanoid production [ J ]. Ann Thorac Surg, 2005, 79 (3) :917 -923.
  • 10杨剑,易定华,钟丽辉,范圣强,曹瑞军,金锋,邵继凤.肝素涂层体外循环管道抗凝血性能的研究[J].生物医学工程与临床,2003,7(2):100-103. 被引量:6

二级参考文献64

  • 1.GB/T 16886.12-1996.医疗器械生物学评价第12部分:样品制备与参照样品中华人民共和国国家标准[S].,..
  • 2.GB/T 16886.5-1997.医疗器械生物学评价第5部分:细胞毒性试验:体外法中华人民共和国国家标准[S].,..
  • 3司徒镇强 见:司徒镇强 吴军正主编.培养细胞生长状况的观察[A].见:司徒镇强,吴军正主编.细胞培养[C].北京:世界图书出版公司,1996.169-179.
  • 4Taylor KM. SIRS-the systemic inflammatory response syndrome after cardiac operations [J]. Ann Thorac Surg, 1996,61 : 1607-1608.
  • 5Belboul A,Akbar O,Lofgren C,et al. Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass[J]. J Cardiovasc Surg,2000,41 : 357-362.
  • 6Larm O,Larsson, Olsson P. Surface-immobilized heparin[M]. In:Lane DA,Lindahl U ed. Hepar in:Chemical and Biological Properties, Clinical Applications. Boca Raton :FL, 1989. 597-608.
  • 7Hsu LC. Principles of heparin-coating techniques [J].Perfusion, 1991,6 : 209-219.
  • 8Jung-Sook B,Eun-Jin S,Inn-Kyu K. Synthesis and characterization of heparinized polyurethanes using plasma glow discharge[J]. Biomaterials, 1999,20: 529-537.
  • 9Yii M,Gourlay T,Fleming J,et al. Evaluation of Carmeda bioactive surface (CBAS), Duraflo Ⅱ and a novel nonspecific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass[J]. Perfusion, 1996,11 : 229-240.
  • 10Boisclair MD,Lane DA,Philippou H,et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass[J]. Blood, 1993,82 : 3350-3357.

共引文献40

同被引文献23

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部